Back to Journals » Hepatic Medicine: Evidence and Research » Volume 6

New-onset ascites as a manifestation of virologic relapse in patients with hepatitis C cirrhosis

Authors Chua D, Hahambis T, Sigal S

Received 27 August 2013

Accepted for publication 13 November 2013

Published 29 January 2014 Volume 2014:6 Pages 11—14


Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 3

Deborah Lim Chua, Thomas Hahambis, Samuel H Sigal

Division of Gastroenterology, Department of Medicine, New York University School of Medicine, New York, NY, USA

Background: Chronic hepatitis C is the most common cause of cirrhosis in industrialized countries. Successful treatment of chronic hepatitis C in patients with advanced fibrosis or cirrhosis has significant benefits, including improvements in inflammation, fibrosis, and portal hypertension, with prevention of esophageal varices and clinical decompensation.
Case: In this report, we present two patients with well-compensated hepatitis C cirrhosis who achieved an end-of-treatment response on a direct-acting antiviral therapy-based triple regimen for hepatitis C virus, but subsequently presented with new-onset ascites associated with virologic relapse.
Conclusion: We propose that the development of ascites in this setting is due to the adverse impact of inflammation of the virologic relapse on portal hypertension. Our observation that ascites formation can be a manifestation of virologic relapse has potentially important clinical implications, as it highlights not only the importance of close monitoring of cirrhotic patients after achieving end-of-treatment response but also the impact of active inflammation on the severity of portal hypertension.

Keywords: chronic hepatitis C, cirrhosis, virologic relapse, portal hypertension, ascites

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]